teduglutide (Revestive®) accepted for use within NHSScotland

The SMC has accepted teduglutide for the treatment of patients age 1 year and above with short bowel syndrome (SBS). Patients should be stable following a period of intestinal adaptation after surgery.

Scottish Medicines Consortium